October 28, 2011
"Questioning the Risk Profile of Selegiline Hydrochloride" Poster exhibit presented by Dr.
Emory at Institute on Psychiatric Services Conference, San Francisco.
May 15-18, 2011
“Questioning the Risk Profile of Selegiline Hydrochloride” Poster exhibit presented by Dr.
Emory at American Psychiatric Association Conference, Honolulu.
- Neurometric Subgroups in Attentional and Affective Disorders and Their Association with
Pharmacotherapeutic Outcome
By Stephen C. Suffin and W. Hamlin Emory
Source: Clinical Electroencephalography ©1995 Vol. 26 No. 2
- Referenced-EEG in the Treatment of Eating Disorders
By Mark Schiller, M.D., W. Hamlin Emory, M.D., Stephen C. Suffin, M.D.
Presented at the 44th Annual NCDEU
- A QEEG Database Method for Predicting Pharmacotherapeutic Outcome in Refractory Major
Depressive Disorder
By Stephen C. Suffin, M.D.; W. Hamlin Emory, M.D.;
Mark J. Schiller, M.D.; Arthur Kling, M.D.
Source: Journal of American Physicians and Surgeons
©2007 Vol. 12 No. 4
- "An Alternative to Standardized Psychiatric Prescribing"
By W. Hamlin Emory, M.D.
published in The Eating Disorder Sourcebook 3rd ed.
by Carolyn Costin, M.A., M.Ed., M.F.T. 2007. 291-294.
- EEG guidance of psychopharmacologic treatment: multi-site experience.
Schiller MJ, Emory WH, Shaffer J, Hamilton JT, Hoffman DA, Davis A. Suffin SS.
(May, 2005).
Poster No. 10 for 158th Annual Meeting of American Psychiatric Association,
Atlanta, GA.
- Referenced –EEG in the treatment of eating disorders.
Emory WH, Schiller M, Suffin SC. (June, 2004).
Poster No. 221 for 44th Annual Meeting
of New Clinical Drug Evaluation Unit (NCDEU). Phoenix, AZ.
- EEG and QEEG as an Adjunct to Clinical Assessment Predicts Response to Atypical Treatment Options.
W. Hamlin Emory, M.D., Mark Shatsky, D.O., C. Wells.
Presented at the 22nd Annual ANPA
Conference, Denver, March, 2011.
- Questioning the Risk Profile of Selegiline Hydrochloride.
W. Hamlin Emory, M.D., Mark Shatsky, D.O., C. Wells.
Presented at the 164th Annual
APA Conference, Honolulu, May, 2011.